(603520)"Zhejiang Starry Pharmaceutical Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance and Cash Dividend Briefing
Filed with SSE · Stock code 603520 · · 3 pages · Chinese
Summary by 6ix AI
Zhejiang Starry Pharmaceutical Co., Ltd. has announced a briefing for its semi-annual performance and cash dividend. The briefing is scheduled for a specific date and will be held online at the Shanghai Stock Exchange Roadshow Center. Company executives will participate and address investor questions during the event. Investors can submit questions in advance through the designated platform before the briefing.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Starry Pharmaceutical Co., Ltd. on 6ix
Story so far
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Resolutions of the 2nd Meeting of the 6th Board of Directors
- Announcement on Results of Shareholding Reduction by the Actual Controller and Completion of Internal Share Transfer Among Persons Acting in Concert
Earlier from Zhejiang Starry Pharmaceutical
- Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Resolutions of the 2nd Meeting of the 6th Board of Directors
- Announcement on Results of Shareholding Reduction by the Actual Controller and Completion of Internal Share Transfer Among Persons Acting in Concert
- Announcement on Release of Pledge over Shares Held by the Controlling Shareholder
- Change in Equity of Shareholders with Over 5% Shares Reaching 1% Threshold
Follow Zhejiang Starry Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Starry Pharmaceutical